BackViridian Therapeutics Overview

Viridian Therapeutics Total Revenue

Revenue analysis for VRDN.

Quarterly Revenue

$141000.00
↑ 95.83% YoY

As of Mar 2026

Annual Revenue (TTM)

$70.92M
↑ 23382.78% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin